Douglas E. James

437 total citations
15 papers, 153 citations indexed

About

Douglas E. James is a scholar working on Surgery, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Douglas E. James has authored 15 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Oncology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Douglas E. James's work include Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Douglas E. James is often cited by papers focused on Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Douglas E. James collaborates with scholars based in United States, Canada and Australia. Douglas E. James's co-authors include Gregory J. Galano, Victor Lopez, Arun Gupta, Answorth A. Allen, Christopher M. Black, Charlotte Kvasnovsky, Richard D. Glick, Andrew R. Hong, Samuel Z. Soffer and Stephen E. Dolgin and has published in prestigious journals such as Blood, The Journal of Immunology and The American Journal of Sports Medicine.

In The Last Decade

Douglas E. James

13 papers receiving 148 citations

Peers

Countries citing papers authored by Douglas E. James

Since Specialization

Citations

This map shows the geographic impact of Douglas E. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. James more than expected).

Fields of papers citing papers by Douglas E. James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. James. The network helps show where Douglas E. James may publish in the future.

Co-authorship network of co-authors of Douglas E. James

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas E. James. A scholar is included among the top collaborators of Douglas E. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas E. James. Douglas E. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Appendiceal Endometriosis: A Rare Case of Endometriosis Mimicking Acute Appendicitis 2025 ·Cureus ·Regent Lee, (unknown), Douglas E. James	0
2	Population pharmacokinetics and pharmacodynamics of nasal glucagon in patients with type 1 or 2 diabetes 2024 ·CPT Pharmacometrics & Systems Pharmacology ·Douglas E. James, Tong Shen, (unknown), Parag Garhyan, Emmanuel Chigutsa	1
3	A Trend Toward More Pigtails and Less Chest Tubes with Similar Outcomes 2021 ·Journal of the American College of Surgeons ·Matthew Bronstein, (unknown), Kartik Prabhakaran, Douglas E. James, Shekhar Gogna, (unknown), (unknown), Peter Rhee	1
4	Resection of Longitudinal Vaginal Septum Using a Surgical Stapler 2020 ·Journal of Pediatric and Adolescent Gynecology ·(unknown), Douglas E. James, (unknown), (unknown), Francisca Velcek	2
5	Limiting hospital resources for acute appendicitis in children: Lessons learned from the U.S. epicenter of the COVID-19 pandemic 2020 ·Journal of Pediatric Surgery ·Charlotte Kvasnovsky, Yan Shi, Barrie S. Rich, Richard D. Glick, Samuel Z. Soffer, Aaron M. Lipskar, Stephen E. Dolgin, Naina Bagrodia, Andrew R. Hong, José M. Prince, Douglas E. James, Chethan Sathya	49
6	Assessment of Transporter Polymorphisms as a Factor in a BCRP Drug Interaction Study With Lanabecestat 2019 ·The Journal of Clinical Pharmacology ·Brian A. Willis, Scott W. Andersen, (unknown), Douglas E. James, Emily Liffick, Kathleen M. Hillgren, Yingying Guo, Scott A. Monk	7
7	Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P‐gp Substrate 2019 ·The Journal of Clinical Pharmacology ·Scott A. Monk, Alan R. Kugler, Scott W. Andersen, (unknown), Douglas E. James, Jamie Mullen, Jennifer A. Zimmer, Brian A. Willis	3
8	腫瘍およびその微小環境におけるラパマイシン(mTOR)蛋白質発現の機構的標的は,おいてにおけるより攻撃的な病理学と相関する【JST・京大機械翻訳】 2018 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Funda Vakar‐Lopez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Douglas E. James, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
9	Population Pharmacokinetics (PK) and Pharmacodynamics (PD) Analysis of LY3015014, a Monoclonal Antibody to Protein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Healthy Subjects and Hypercholesterolemia Patients 2016 ·Pharmaceutical Research ·Tong Shen, Douglas E. James, Kathryn A. Krueger	11
10	Congenital mesoblastic nephroma with distant metastasis in a premature twin gestation 2016 ·Journal of Pediatric Surgery Case Reports ·Douglas E. James, Jason P. Sulkowski, Michael C. Smith, A Barone, (unknown), (unknown), Francisca Velcek	0
11	P1‐044: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of LY3202626, a Novel Bace1 Inhibitor, in Healthy Subjects and Patients with Alzheimer’s Disease 2016 ·Alzheimer s & Dementia ·Brian A. Willis, Stephen L. Lowe, (unknown), Robert A. Dean, Brett A. English, Larry Ereshefsky, Hakop Gevorkyan, Douglas E. James, Stanford S. Jhee, Qun Lin, Albert Lo, Dustin J. Mergott, Scott A. Monk, Masako Nakano, Jennifer A. Zimmer, Michael C. Irizarry	7
12	The Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Evacetrapib Administered as Monotherapy or in Combination With Statins 2014 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), JJP Kastelein, Douglas E. James, (unknown), (unknown), (unknown), K Krueger	17
13	Profile of an American Amateur Rugby Union Sevens Series 2011 ·The American Journal of Sports Medicine ·Victor Lopez, Gregory J. Galano, Christopher M. Black, Arun Gupta, Douglas E. James, (unknown), Answorth A. Allen	44
14	A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431 2011 ·Blood ·Michael A. Pulsipher, Bryan Langholz, Donna A. Wall, Kirk R. Schultz, Nancy Bunin, William L. Carroll, Elizabeth A. Raetz, Sharon L. Gardner, Julie M. Gastier‐Foster, Denise L. Howrie, Rakesh K. Goyal, Douglas E. James, Michael J. Borowitz, Yvonne Barnes, Shivanand R. Patil, David T. Teachey, (unknown), Stephan A. Grupp	1
15	The Relative Timing of Exposure to Phagocytosable Particulates and to Osteoclastogenic Cytokines Is Critically Important in the Determination of Myeloid Cell Fate 2010 ·The Journal of Immunology ·Douglas E. James, Bryan J. Nestor, Thomas P. Sculco, Lionel B. Ivashkiv, F. Patrick Ross, Steven R. Goldring, P. Edward Purdue	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact